Navigation Links
Amarin's AMR101 Phase 3 ANCHOR Trial Meets all Primary and Secondary Endpoints with Statistically Significant Reductions in Triglycerides at Both 4 Gram and 2 Gram Doses and Statistically Significant Decrease in LDL-C
Date:4/17/2011

lyceride lowering therapies and position AMR101 to be both first-in-class and best overall therapy for treating the high triglyceride population. We thank the ANCHOR team, including our investigators, for their many contributions to this outstanding study design and execution."

Large Market Potential

In the U.S. alone, approximately 40 million people have triglyceride levels above 200 mg/dL. The majority of these patients have high triglyceride levels of ≥200 and <500mg/dL as studied in the ANCHOR trial with approximately 4 million of these people having very triglyceride levels >500 mg/dL as studied in the MARINE trial.  Currently, no omega-3 based product is approved for the indication studied in the ANCHOR trial.  In the seven largest pharmaceutical markets (U.S., Japan and five largest European markets), it is estimated that over 100 million people have mixed dyslipidemia.  

Conference Call and Webcast Information

Amarin will host a conference call at 8:00 a.m. EDT today, April 18, 2011, to comment on the ANCHOR results and the Company's current operating and strategic objectives. To participate in the call, please dial (877) 407-0778 within the U.S. or (201) 689-8565 from outside the U.S.  A replay of the call will be made available for a period of two weeks following the conference call. To hear a replay of the call dial (877) 660-6853 (inside the U.S.) or (201) 612-7415 (outside the U.S.).  A replay of the call will also be available via the Company's Web site shortly after the call. For both dial-in numbers please use account number 286 and conference ID 371147.  The conference call can also be heard live via the investor relations section of the Company's Web site at www.amarincorp.com.  

About ANCHOR

The ANCHOR trial, a multi-center, placebo-controlled, randomized, double-blind, 12-week pivotal stud
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 A study led by St. ... chemotherapy dose threshold below which male childhood cancer survivors ... appears in September 17 edition of the journal ... are at highest risk for reduced sperm production as ... of pre-treatment fertility preservation methods such as sperm banking. ...
(Date:9/16/2014)... Ill. , Sept. 16, 2014 ... new director of Business Communications & Advocacy, Urology ... President, Business Communications & Advocacy Margaret Long. In this ... commitment to urology to patient and advocacy organizations, ... teams on key strategic initiatives. Noland,s appointment is ...
(Date:9/16/2014)... , Sept. 16, 2014 /PRNewswire-iReach/ -- Dan ... GWM Products, LLC, manufacturer of the RTD ® ... plan to expand its sales presence in the U.S. ... hiring and training direct field sales representatives in new ... The company plans to add up to 20 sales ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2GWM Products, LLC, announces U.S. market expansion. Dan York added as Director of Sales as part of nationwide growth initiative. 2
... Va., Oct. 30 CEL-SCI Corporation,(Amex: CVM ) ... at the Rodman & Renshaw 9th Annual Healthcare Conference ... 5-7, 2007. The presentation,will be focused on its Phase ... product seeking to become a new first line standard ...
... the Potential ... INDIANAPOLIS and MUMBAI, India, Oct. 30 Eli,Lilly and Company ... into an,agreement with Glenmark Pharmaceuticals S.A. (GPSA) a wholly owned,subsidiary ... agreement, Lilly will acquire the rights to a portfolio of ...
Cached Medicine Technology:CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5
(Date:9/17/2014)... ATLANTA, GA (PRWEB) September 17, 2014 ... Contact Center software, has launched Presence Suite 10.0, ... journey and improve the customer experience. , The ... autonomy and flexibility. Now supervisors can get a ... and understand who is contributing most and who ...
(Date:9/16/2014)... 17, 2014 Recently, BamboofloorChina.com, the popular ... new assortment of strand woven bamboo floors ... launched a big promotion for the new items; the ... , Autumn is a great shopping season. Therefore, BamboofloorChina.com ... old and new customers. All practical items offered by ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Dog Food ... dog owners the true poisonous ingredients in most commercial dog ... recipes has caught the attention of Shane Michaels, prompting an ... just as much of a family member as any other ... dog dies earlier than it should due to poor diet” ...
(Date:9/16/2014)... Retinol is favored by a majority of dermatologists and ... so many benefits - it is one of those amazing ... Sublime Beauty . "Healthy skin is our goal, and Retinol ... Retinol Serum with Vitamin C is a non-irritating, silky serum ... Retinol Serum with Vitamin C is now 30% ...
(Date:9/16/2014)... City, UT (PRWEB) September 16, 2014 ... Benefits Solution, published new information on transitioning employees ... Zane Benefits, with the Affordable Care Act (ACA) ... businesses will be steering some or all of ... as no surprise. With guaranteed issue plans, coverage ...
Breaking Medicine News(10 mins):Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2Health News:Retinol, the Gold Standard in Skin Care, Available in a Serum with Vitamin C from Sublime Beauty®; Now 30% Off 2Health News:Zane Benefits Publishes New Information on Transitioning Employees to Individual Health Insurance 2
... Walk on the Capitol,is proud to announce Caitlin Van ... guest speaker for our National obesity awareness event,in Washington, ... Capitol is a,history-making awareness event that will gather thousands ... the obesity epidemic and,the need for expanded efforts in ...
... 2 ,Dawning Technologies, Inc. (Dawning) and Medical Automation ... joint project to leverage their,product synergies and create ... project will focus on the seamless integration of ... RALS(R)-,Plus POC Data Management solutions. RALS-Plus is a ...
... Merger, CHICAGO, June 2 Allscripts, the ... that,physicians use to improve healthcare, announced today that ... Act of,1976, with respect to the merger agreement ... Healthcare to form Allscripts-Misys Healthcare,Solutions, Inc., has expired., ...
... MONTREAL, June 2 /PRNewswire-FirstCall/ - Haemacure ... company developing,high-value human plasma-derived protein products for ... quarter results., Financing, As a ... to-date from key,shareholders to exercise their Series ...
... care deserves more funding for estimated 2.5 million displaced ... removed from their homes due to mistreatment have fewer ... kinship care -- than if they,re placed in foster ... by researchers at Children,s Hospital of Philadelphia, looked at ...
... are similar to the type diagnosed in Sen. Edward ... experimental cancer vaccine is showing promise against the same ... Kennedy, researchers are reporting. , The vaccine, when given ... with glioblastoma multiforme tumors. Kennedy was diagnosed last month ...
Cached Medicine News:Health News:Television Star Caitlin Van Zandt Signs-on as Special Guest Speaker for National Obesity Awareness Event in Washington, DC, on June 17 2Health News:Dawning Technologies, Inc. and Medical Automation Systems, Inc. to Develop a Business Partnership 2Health News:Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement 2Health News:Haemacure Reports on Financing Progress and Second Quarter Results 2Health News:Haemacure Reports on Financing Progress and Second Quarter Results 3Health News:Kids Living With Relatives Have Fewer Problems Than Those in Foster Homes 2Health News:Vaccine May Boost Survival of Brain Cancer Patients 2Health News:Vaccine May Boost Survival of Brain Cancer Patients 3
... Predictor Test is a qualitative, one-step, ... Follicle Stimulating Hormone (FSH) in urine ... changes related to the symptoms associated ... The FHS Menopause Predictor Test is ...
Serim PyloriTek Test Kit detects urease activity in gastric biopsy specimens for the presumptive identification of an Helicobacter pylori infection....
Immunoassay for rapid, qualitative detection of IgG antibodies specific to Helicobacter pylori in whole blood....
... The Accutest H. pylori ... test for the qualitative detection ... Helicobacter pylori in human whole ... intended as an aid in ...
Medicine Products: